Literature DB >> 9452921

Pathophysiology of Rett syndrome from the standpoint of early catecholamine disturbance.

M Segawa1.   

Abstract

The polysomnography of Rett syndrome (RS) revealed early disturbance, hypofunctioning, of the noradrenaline, serotonin, and dopamine neurons. Neuropathologically, early lesions of the dopamine neurons in the pars compacta of the substantia nigra and the ventrotegmental areas were observed. These aminergic neurons have roles in the functional maturation of their targets in the brain and for synaptogenesis of the cortex at critical ages. Early hypofunctioning of the dopamine neurons results in receptor supersensitivity of the receptors, which could cause the characteristic clinical features of RS in which particular signs and symptoms appear age dependently. The correlating lesions of the cholinergic neurons in the Meynert basal nucleus might relate to the deterioration of higher cortical function which becomes apparent from early childhood.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9452921

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  4 in total

1.  Substance P modulation of TRPC3/7 channels improves respiratory rhythm regularity and ICAN-dependent pacemaker activity.

Authors:  Faiza Ben-Mabrouk; Andrew K Tryba
Journal:  Eur J Neurosci       Date:  2010-03-19       Impact factor: 3.386

Review 2.  Neuromodulation and the orchestration of the respiratory rhythm.

Authors:  Atsushi Doi; Jan-Marino Ramirez
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

3.  Sleep problems in Rett syndrome.

Authors:  Deidra Young; Lakshmi Nagarajan; Nick de Klerk; Peter Jacoby; Carolyn Ellaway; Helen Leonard
Journal:  Brain Dev       Date:  2007-05-24       Impact factor: 1.961

4.  Overshooting Subcellular Redox-Responses in Rett-Mouse Hippocampus during Neurotransmitter Stimulation.

Authors:  Karina Festerling; Karolina Can; Sebastian Kügler; Michael Müller
Journal:  Cells       Date:  2020-11-24       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.